Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Upland Software
UPLD
$13.3M
| $56.7K | ﹤0.01% |
2,278
| – | – |
|
|
BOLD
3502
Boundless Bio
BOLD
$55.7M
| $56.7K | ﹤0.01% |
+14,649
| New | +$140K |
|
3503
CDT Equity Inc
CDT
$1.61M
| – | – |
0
| – | – |
|
3504
ClearPoint Neuro
CLPT
$424M
| $55.9K | ﹤0.01% |
10,369
-52,401
| -83% | -$303K |
|
3505
RenovoRx
RNXT
$40.5M
| $55.6K | ﹤0.01% |
49,232
| – | – |
|
|
CHMI
3506
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
| $54.5K | ﹤0.01% |
15,001
| – | – |
|
3507
Grove Collaborative
GROV
$45.8M
| $54K | ﹤0.01% |
30,520
| – | – |
|
3508
AXT Inc
AXTI
$2.42B
| $53.7K | ﹤0.01% |
15,887
| – | – |
|
3509
LENSAR
LNSR
$64.5M
| $53.3K | ﹤0.01% |
11,846
| – | – |
|
3510
Telomir Pharmaceuticals
TELO
$83.2M
| $52.2K | ﹤0.01% |
+10,850
| New | +$67.7K |
|
|
KYNB
3511
Kyntra Bio
KYNB
$27.4M
| $51.8K | ﹤0.01% |
2,321
-8,366
| -78% | -$259K |
|
|
ARC
3512
DELISTED
ARC Document Solutions, Inc.
ARC
| $50.3K | ﹤0.01% |
19,042
| – | – |
|
|
LUNA
3513
DELISTED
Luna Innovations Incorporated
LUNA
| $49.9K | ﹤0.01% |
15,596
-72,680
| -82% | -$216K |
|
|
ASRT
3514
DELISTED
Assertio
ASRT
| $49.8K | ﹤0.01% |
2,676
-13,645
| -84% | -$203K |
|
3515
Atomera
ATOM
$173M
| $47.6K | ﹤0.01% |
12,488
-52,430
| -81% | -$247K |
|
|
GAN
3516
DELISTED
GAN Ltd
GAN
| $46.4K | ﹤0.01% |
31,476
| – | – |
|
3517
Research Solutions
RSSS
$74.9M
| $46.1K | ﹤0.01% |
18,069
| – | – |
|
|
IVAC
3518
DELISTED
Intevac Inc
IVAC
| $45.9K | ﹤0.01% |
11,887
-58,321
| -83% | -$230K |
|
3519
Tigo Energy
TYGO
$117M
| $45.6K | ﹤0.01% |
29,611
+184
| +0.6% | +$231 |
|
3520
Citius Pharmaceuticals
CTXR
$15.6M
| $44.4K | ﹤0.01% |
3,043
-11,237
| -79% | -$201K |
|
3521
Intellicheck
IDN
$75.1M
| $44.3K | ﹤0.01% |
12,962
| – | – |
|
3522
Karyopharm Therapeutics
KPTI
$155M
| $44.2K | ﹤0.01% |
3,400
-17,261
| -84% | -$286K |
|
3523
Genasys
GNSS
$76.5M
| $44.2K | ﹤0.01% |
20,918
| – | – |
|
3524
Eton Pharmaceutcials
ETON
$1.32B
| $43.6K | ﹤0.01% |
13,239
| – | – |
|
3525
Wrap Technologies
WRAP
$90.9M
| $43.2K | ﹤0.01% |
21,615
+100
| +0.5% | +$174 |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.